131
Participants
Start Date
May 29, 2019
Primary Completion Date
September 30, 2027
Study Completion Date
April 27, 2028
Spesolimab
Solution for infusion
Spesolimab
Solution for injection
Chang Gung Medical Foundation (CGMF) - Linkou Bran, Linkou District
La Rabta Hospital, Tunis
Hedi Chaker Hospital, Department of Dermatology, Tunisia
Cliniques Universitaires Saint-Luc, Brussels
Center for Skin Research, Testing and Product Development, Makati City
Farhat Hached Hospital, Sousse
Iloilo Doctors Hospital, Iloilo City, Iloilo
Southern Philippines Medical Center -Davao-62091, Davao City
National Hospital of Dermatology and Venereology, Hà Nội
National Taiwan University Hospital, Taipei
Icahn School of Medicine at Mount Sinai, New York
Charite Universitätsmedizin Berlin KöR, Berlin
Institute of Dermatology, Bangkok
Ramathibodi Hospital, Bangkok
Hospital Pulau Pinang-Pulau Pinang-21953, George Town
Istituto Clinico Humanitas, Rozzano (MI)
Klinikum Oldenburg AöR, Oldenburg
Hospital Raja Permaisuri Bainun, Ipoh
HOP Saint-André, Bordeaux
Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul
Westfälische Wilhelms-Universität Münster, Münster
Oakland Hills Dermatology, Auburn Hills
Fachklinik Bad Bentheim, Bad Bentheim
Hospital Kuala Lumpur, Kuala Lumpur
HOP Robert Debré, Reims
Universitätsklinikum Bonn AöR, Bonn
Universitätsklinikum Frankfurt, Frankfurt am Main
Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey
Hospital Selayang, Kuala Selangor
HCMC Hospital of Dermato-Venereology-Ho Chi Minh-66092, Ho Chi Minh City
HOP Saint-Louis, Paris
Hospital Sultanah Aminah, Johor Bahru
Klinikum der Universität München - Campus Innenstadt, München
Hospital Sultan Ismail, Johor Bahru
Hospital Pakar Sultanah Fatimah, Muar town
Queen Elizabeth Hospital-Kota Kinabalu-40735, Kota Kinabalu
Sarawak General Hospital, Kuching, Sarawak
Singapore General Hospital, Singapore
LLC Skin Disease Clinic of Pier Volkenstein, St. Petersburg, Saint Petersburg
Shanghai Skin Disease Hospital, Shanghai
Huashan Hospital, Fudan University, Shanghai
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Saratov State Med.Univ.n.a.Razumovskogo, Saratov
"LLC Medical Center Azbuka Zdorovia", Kazan'
SBHI Chelyabinsk Reg.Clin.Derma.Dispen., Chelyabinsk
Sun yet-sen Memorial Hospital, Sun yet-sen Univesity, Guangzhou
"FSBEI HE Kirov State Medical University", Kirov
Second Affiliated Hospital of Xi'an JiaoTong University, Xi'an
Clínica Dermacross S.A., Vitacura
Hospital Italiano de Buenos Aires, CABA
HOP l'Archet, Nice
Nagoya City University Hospital, Aichi, Nagoya
Tokyo Medical University Ibaraki Medical Center, Ibaraki, Inashiki-gun
Saitama Medical University Hospital, Saitama, Iruma-gun
Tokyo Medical University Hachioji Medical Center, Tokyo, Hachioji
Severance Hospital, Seoul
Hospital Sant Joan de Déu, Esplugues Del Llobregat
Lead Sponsor
Boehringer Ingelheim
INDUSTRY